Abstract
The GH/IGF-I axis has essential roles in regulating bone and vascular status. The age-related decrease in GH secretion (“somatopause”) may contribute to osteoporosis and atherosclerosis, commonly observed in the elderly. Adult-onset GH deficiency (GHD) has been reported to be associated with reduced bone mineral density (BMD), increased risk of fractures, and premature atherosclerosis. We have shown the young adult individuals with isolated GHD (IGHD) due to a homozygous for the c.57+1G>A GHRH receptor gene mutation have normal volumetric BMD (vBMD), and not develop premature atherosclerosis, despite adverse risk factor profile. However, the bone and vascular impact of lifetime GHD on the aging process remains unknown. We studied a group of ten older IGHD subjects (≥60 years) homozygous for the mutation, comparing them with 20 age- and gender-matched controls (CO). Areal BMD was measured, and vBMD was calculated at the lumbar spine and total hip. Vertebral fractures and abdominal aortic calcifications (expressed as calcium score) were also assessed. Areal BMD was lower in IGHD, but vBMD was similar in the two groups. The percent of fractured individuals was similar, but the mean number of fractures per individual was lower in IGHD than CO. Calcium score was similar in the two groups. A positive correlation was found between calcium score and number of fractures. Untreated lifetime IGHD has beneficial consequences on bone status and does not have a deleterious effect on abdominal aorta calcification.
Similar content being viewed by others
References
D.J. Vaness, A.N.A. Tosteson, Estimating the opportunity costs of osteoporosis in the United States. Topics Geriatr. Rehab. 21, 4–16 (2005)
G.A. Mensah, D.W. Brown, An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) 26, 38–48 (2007)
P.C. Watanabe, F.C. Dias, J.P. Issa, S.A. Monteiro, F.J. de Paula, R. Tiossi, Elongated styloid process and atheroma in panoramic radiography and its relationship with systemic osteoporosis and osteopenia. Osteoporos. Int. 21, 831–836 (2010)
E.M. Lewiecki, A.J. Laster, Clinical review: clinical applications of vertebral fracture assessment by dual-energy X-ray absorptiometry. J. Clin. Endocrinol. Metab. 91, 4215–4222 (2006)
A. El Maghraoui, F. Morjane, A. Nouijai, L. Achemlal, A. Bezza, I. Ghozlani, Vertebral fracture assessment in Moroccan women: prevalence and risk factors. Maturitas 62, 171–175 (2009)
J.F. Griffith, H.K. Genant, New advances in imaging osteoporosis and its complications. Endocrine 42, 39–51 (2012)
G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58–69 (2012)
J.T. Schousboe, B.C. Taylor, D.P. Kiel, K.E. Ensrud, K.E. Wilson, E.V. McCloskey, Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in older women. J. Bone Miner. Res. 23, 409–416 (2008)
M.B.R. Patel, N.K. Arden, L.M. Masterson, D.I.W. Phillips, R. Swaminathan, H.E. Syddall, C.D. Byrne, P.J. Wood, C. Cooper, R.I. Holt, Hertfordshire Cohort Study Group. Investigating the role of growth hormone–insulin-like growth factor (GH–IGF) axis as a determinant of male bone mineral density (BMD). Bone 37, 833–841 (2005)
H. Mochizuki, Y. Hakeda, N. Wakatsuki, N. Usui, S. Akashi, T. Sato, K. Tanaka, M. Kumegawa, Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131, 1075–1080 (1992)
P. Gillberg, H. Olofsson, H. Mallmin, W.F. Blum, S. Ljunghall, A.G. Nilsson, Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif. Tissue Int. 70, 22–29 (2002)
C. Ohlsson, B.-A. Bengtsson, O.G.P. Isaksson, T.T. Andreassen, M.C. Slootweg, Growth hormone and bone. Endocr. Rev. 19, 55–79 (1998)
A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–539 (2008)
P. Delafontaine, Y.H. Song, Y. Li, Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 24, 435–444 (2004)
D. Rudman, Growth hormone, body composition, and aging. J. Am. Geriatr. Soc. 33, 800–807 (1985)
Y. Higashi, S. Sukhanov, A. Anwar, S.Y. Shai, P. Delafontaine, Aging, atherosclerosis and IGF-I. J. Gerontol. A Biol. Sci. Med. Sci. 67, 626–639 (2012)
G.I. Baroncelli, S. Bertelloni, F. Sodini, G. Saggese, Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 16, 327–335 (2003)
C. Wüster, R. Abs, B.A. Bengtsson, H. Bennmarker, U. Feldt-Rasmussen, E. Hernberg-Ståhl, J.P. Monson, B. Westberg, P. Wilton, The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J. Bone Miner. Res. 16, 398–405 (2001)
T. Rosén, B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285–288 (1990)
M. Gola, S. Bonadonna, M. Doga, A. Giustina, Clinical review: growth hormone and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 90, 1864–1870 (2005)
R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips 3rd, A.H. Souza, R.G. Gondo, S.P. Toledo, M.M. Conceicão, M. Prince, H.G. Maheshwari, G. Baumann, M.A. Levine, Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84, 917–923 (1999)
M.H. Aguiar-Oliveira, M.S. Gill, E.S. de A Barretto, M.R. Alcântara, F. Miraki-Moud, C.A. Menezes, A.H. Souza, C.E. Martinelli, F.A. Pereira, R. Salvatori, M.A. Levine, S.M. Shalet, C. Camacho-Hubner, P.E. Clayton, Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J Clin Endocrinol Metab. 84, 4118–4126 (1999)
E.S. de A Barretto, M.S. Gill, M.E. De Freitas, M.M. Magalhães, A.H. Souza, M.H. Aguiar-Oliveira, P.E. Clayton, Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in growth hormone-releasing hormone (GHRH) receptor. Clin. Endocrionl. (Oxf) 51, 559–564 (1999)
J.A. Barreto-Filho, M.R. Alcântara, R. Salvatori, M.A. Barreto, A.C. Sousa, V. Bastos, A.H. Souza, R.M. Pereira, P.E. Clayton, M.S. Gill, M.H. Aguiar-Oliveira, Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. J. Clin. Endocrionol. Metab. 87, 2018–2023 (2002)
H.K. Gleeson, A.H. Souza, M.S. Gill, G.E. Wieringa, E.S. Barretto, J.A. Barretto-Filho, S.M. Shalet, M.H. Aguiar-Oliveira, P.E. Clayton, Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan. Clin. Endocrinol. (Oxf). 57, 89–95 (2002)
C.R. Oliveira, R. Salvatori, R.A. Meneguz-Moreno, M.H. Aguiar-Oliveira, R.M. Pereira, E.H. Valença, V.P. Araújo, N.T. Farias, D.C. Silveira, J.G. Vieira, J.A. Barreto-Filho, Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 95, 693–698 (2010)
C.R. Oliveira, R. Salvatori, J.A. Barreto-Filho, I.E. Rocha, A. Mari, R.M. Pereira, V.C. Campos, M. Menezes, E. Gomes, R.A. Meneguz-Moreno, V.P. Araújo, N.T. Leite, A.C. Nascimento-Junior, M.I. Farias, T.A. Viscente, R.D. Araújo, E.V. Melo, M.H. Aguiar-Oliveira, Insulin sensitivity and β-cell function in adults with lifetime, untreated isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 97, 1013–1019 (2012)
J.L. Menezes Oliveira, C. Marques-Santos, J.A. Barreto-Filho, R. Ximenes Filho, A.V. de Oliveira Britto, A.H. Oliveira Souza, C.M. Prado, C.R. Pereira Oliveira, R.M. Pereira, A. Ribeiro Vicente Tde, C.T. Farias, M.H. Aguiar-Oliveira, R. Salvatori, Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone deficiency due to a GHRH receptor mutation. J. Clin. Endocrinol. Metab. 91, 2093–2099 (2006)
M.H. Aguiar-Oliveira, F.T. Oliveira, R.M. Pereira, C.R. Oliveira, A. Blackford, E.H. Valenca, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95, 714–721 (2010)
C.C. Epitácio-Pereira, G.M. Silva, R. Salvatori, J.A. Santana, F.A. Pereira, M.B. Gois-Junior, A.V. Britto, C.R. Oliveira, A.H. Souza, E.G. Santos, V.C. Campos, R.M. Pereira, E.H. Valença, R.A. Barbosa, M.I. Farias, F.J. de Paula, T.V. Ribeiro, M.C. Oliveira, M.H. Aguiar-Oliveira, Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size, but not density of trabecular and mixed bone. J. Clin. Endocrinol. Metab. 98(11), E1710–E1715 (2013). doi:10.1210/jc.2013-2349
M.C. Lansang, G.H. Williams, J.S. Carroll, Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am. J. Hypertens. 14, 51–53 (2001)
D.R. Carter, M.L. Bouxsein, R. Marcus, New approaches for interpreting projected bone densitometry data. J. Bone Miner. Res. 7, 137–245 (1992)
D.K. Katzman, L.K. Bachrach, D.R. Carter, R. Marcus, Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J. Clin. Endocrinol. Metab. 73, 1332–1339 (1991)
H.G. Maheshwari, R. Bouillon, J. Nijs, V.S. Oganov, A.V. Bakulin, G. Baumann, The impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency. J. Clin. Endocrinol. Metab. 88, 2614–2618 (2003)
D. Diacinti, G. Guglielmi, D. Pisani, D. Diacinti, R. Argirò, C. Serafini, E. Romagnoli, S. Minisola, C. Catalano, V. David, Vertebral morphometry by dual-energy X-ray absorptiometry (DXA) for osteoporotic vertebral fractures assessment (VFA). Radiol. Med. 117, 1374–1385 (2012)
H.K. Genant, C.Y. Wu, C. van Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 8, 1137–1148 (1993)
L.K. Bachrach, R. Marcus, S.M. Ott, A.L. Rosenbloom, O. Vasconez, V. Martinez, A.L. Martinez, R.G. Rosenfeld, J. Guevara-Aguirre, Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J. Bone Miner. Res. 13, 415–421 (1998)
C.A. Benbassat, V. Eshed, M. Kamjin, Z. Laron, Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities. J. Clin. Endocrinol. Metab. 88, 4586–4589 (2003)
A. Iranmanesh, G. Lizarralde, J.D. Veldhuis, Age and relative obesity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73(5), 1081–1088 (1991)
J.L. Wémeau, Calciotropic hormones and ageing. Horm. Res. 43, 76–79 (1995)
S. Perrini, L. Laviola, M.C. Carreira, A. Cignarelli, A. Natalicchio, F. Giorgino, The GH/IGF-I axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201–210 (2010)
E. Schoenau, From mechanostat theory to development of the “Functional Muscle-Bone-Unit”. J. Musculoskelet. Neuronal. Interact. 5, 232–238 (2007)
N.A. Sims, P. Clément-Lacroix, F. Da Ponte, Y. Bouali, N. Binart, R. Moriggl, V. Goffin, K. Coschigano, M. Gaillard-Kelly, J. Kopchick, R. Baron, P.A. Kelly, Bone homeostasis in growth hormone receptor null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest. 106, 1095–1103 (2000)
W.H. Beamer, E.M. Eicher, Stimulation of growth in the little mouse. J. Endocrinol. 71, 37–45 (1976)
H.A. Fink, D.L. Milavetz, L. Palermo, M.C. Nevitt, J.A. Cauley, H.K. Genant, D.M. Black, K.E. Ensrud, What proportional of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J. Bone Miner. Res. 20, 1216–1222 (2005)
N. de Oliveira Ferreira, R.B. da Silva, M. Arthuso, A.M. Pinto-Neto, N. Caserta, L. Costa-Paiva, Prevalence of vertebral fractures and quality of life in a sample of postmenopausal Brazilian women with osteoporosis. Arch. Osteoporos. 7, 101–106 (2012)
J.A. Barbosa, R. Salvatori, C.R. Oliveira, R.M. Pereira, C.T. Farias, A.V. Britto, N.T. Farias, A. Blackford, M.H. Aguiar-Oliveira, Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency. Psychoneuroendocrinology 34, 894–900 (2009)
V.N. Anisimov, A. Bartke, The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer. Crit. Rev. Oncol. Hemat. 87, 201–223 (2013)
P. Szulc, E.J. Samelson, E. Sornay-Rendu, R. Chapurlat, D.P. Kiel, Severity of aortic calcification is positively associated with vertebral fracture in older men—a densitometry study in the STRAMBO cohort. Osteoporos. Int. 24, 1177–1848 (2013)
G. Rajzbaum, V.L. Roger, Y. Bézie, M. Chauffert, P. Bréville, F. Roux, M.E. Safar, J. Blacher, French women, fractures and aortic calcifications. J. Intern. Med. 257, 117–119 (2005)
P. Szulc, D.P. Kiel, P.D. Delmas, Calcifications in the abdominal aorta predict fractures in men: MINOS study. J. Bone Miner. Res. 23, 95–102 (2008)
J. Iwamoto, H. Matsumoto, T. Takeda, Y. Sato, M. Uzawa, A radiographic study on the associations of age and prevalence of vertebral fractures with abdominal aortic calcification in Japanese postmenopausal women and men. J. Osteoporos. (2010). doi:10.4061/2010/748380
G.S. Tajeu, E. Delzell, W. Smith, T. Arora, J.R. Curtis, K.G. Saag, M.A. Morrisey, H. Yun, M.L. Kilgore, Death, Debility, and Destitution Following Hip Fracture. J. Gerontol. A Biol. Sci. Med. Sci. (2013). doi:10.1093/gerona/glt105
N.F. Ray, J.K. Chan, M. Thamer, L.J. Melton 3rd, Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J. Bone Miner. Res. 12, 24–35 (1997)
J. Morales-Torres, S. Gutiérrez-Ureña, The burden of osteoporosis in Latin America. Osteoporos. Int. 15, 625–632 (2004)
J. Damilakis, J.E. Adams, G. Guglielmi, T.M. Link, Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur. Radiol. 20, 2707–2714 (2010)
S.J. Gallacher, A.P. Gallagher, C. McQuillian, P.J. Mitchell, T. Dixon, The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos. Int. 18, 185–192 (2007)
J.T. Schousboe, C.R. Debold, Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos. Int. 17, 281–289 (2006)
D.R. Owen, A.C. Lindsay, R.P. Choudhury, Z.A. Fayad, Imaging of atherosclerosis. Ann. Rev. Med. 62, 25–40 (2011)
J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, G.M. London, Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38, 938–942 (2001)
G.M. London, Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J. Am. Soc. Nephrol. 14, S305–S309 (2003)
M. Cecelja, M.L. Frost, T.D. Spector, P. Chowienczyk, Abdominal aortic calcification detection using dual-energy X-ray absorptiometry: validation study in healthy women compared to computed tomography. Calcif. Tissue Int. 92, 495–500 (2013)
T.A. Vicente, I.E. Rocha, R. Salvatori, C.R. Oliveira, R.M. Pereira, A.H. Souza, V.C. Campos, E.G. Santos, R.D. Diniz, E.H. Valença, C.C. Epitácio-Pereira, M.C. Oliveira, A. Mari, M.H. Aguiar-Oliveira, Lifetime congenital isolated GH deficiency does not protect from the development of diabetes. Endocr. Connect. 2, 112–117 (2013)
Acknowledgments
We thank the Clinic CLIMEDI (Av. Barao de Maruim, 570, Aracaju-SE, 49000-000) for the BMD measurements.
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Ethical standard
The Institutional Review Board of the Federal University of Sergipe approved the protocol. Written informed consent was obtained from all subjects.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Souza, A.H.O., Farias, M.I.T., Salvatori, R. et al. Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals, and does not influence their abdominal aorta calcification. Endocrine 47, 191–197 (2014). https://doi.org/10.1007/s12020-013-0118-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0118-5